ArticleDiabetes therapy : research, treatment and education of diabetes and related disorders2020

Efficacy and Safety of iGlarLixi, Fixed-Ratio Combination of Insulin Glargine and Lixisenatide, Compared with Basal-Bolus Regimen in Patients with Type 2 Diabetes: Propensity Score Matched Analysis.

Ádám G Tabák et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.